Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Mol Omics. 2020 Mar 23;16(3):195–209. doi: 10.1039/d0mo00009d

Table 1. Altered Fucosyltransferase Expression in Response to β-catenin/CBP Inhibition.

Expression change of fucosyltransferases FUT2, FUT3, FUT8, the epidermal growth factor receptor (EGFR), and E-cadherin (CDH1) after treatment with ICG-001 (top) or E7386 (bottom) compared to vehicle control (DMSO) in indolent CAL27 and metastatic HSC-3 cells. The fold change of the treatment compared to the DMSO control (Fold Δ) and q-value (q, FDR adjusted) are shown for each condition tested.

ICG-001 v Vehicle
HSC-3 CAL27
Fold Δ q Fold Δ q
FUT2 +2.1 2.0 × 10−5 +1.1 5.4 × 10−1
FUT3 +3.0 5.7 × 10−8 +1.4 1.5 × 10−1
FUT8 +1.2 9.0 × 10−3 +1.2 1.2 × 10−1
EGFR +1.1 3.9 × 10−1 +1.3 2.1 × 10−2
CDH1 +1.2 5.1 × 10−2 −1.1 3.6 × 10−1
E7386 v Vehicle
HSC-3 CAL27
Fold Δ q Fold Δ q
FUT2 +2.4 1.4 × 10−3 NC -
FUT3 +2.3 5.5 × 10−4 +1.6 1.8 × 10−2
FUT8 +1.4 5.0 × 10−3 +1.1 2.6 × 10−1
EGFR +1.5 3.3 × 10−3 +1.5 1.3 × 10−2
CDH1 +1.2 8.1 × 10−2 −1.1 6.3 × 10−1